These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31738187)

  • 1. Are genetic approaches still needed to cure sickle cell disease?
    Brodsky RA; DeBaun MR
    J Clin Invest; 2020 Jan; 130(1):7-9. PubMed ID: 31738187
    [No Abstract]   [Full Text] [Related]  

  • 2. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease.
    Justus DG; Manis JP
    Transfus Apher Sci; 2021 Feb; 60(1):103059. PubMed ID: 33541761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
    Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
    Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promise of gene therapy to treat sickle cell disease.
    Romero Z; DeWitt M; Walters MC
    Expert Opin Biol Ther; 2018 Nov; 18(11):1123-1136. PubMed ID: 30324810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy: Erasing sickle-cell disease.
    Bourzac K
    Nature; 2017 Sep; 549(7673):S28-S30. PubMed ID: 28953858
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene Therapy for β-Hemoglobinopathies.
    Cavazzana M; Antoniani C; Miccio A
    Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
    Dong AC; Rivella S
    Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.
    Urbinati F; Wherley J; Geiger S; Fernandez BC; Kaufman ML; Cooper A; Romero Z; Marchioni F; Reeves L; Read E; Nowicki B; Grassman E; Viswanathan S; Wang X; Hollis RP; Kohn DB
    Cytotherapy; 2017 Sep; 19(9):1096-1112. PubMed ID: 28733131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy for sickle cell disease: transplantation and gene therapy.
    Walters MC
    Hematology Am Soc Hematol Educ Program; 2005; ():66-73. PubMed ID: 16304361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
    Anurogo D; Yuli Prasetyo Budi N; Thi Ngo MH; Huang YH; Pawitan JA
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation for sickle cell disease: can we reduce the toxicity?
    Fixler J; Vichinsky E; Walters MC
    Pediatr Pathol Mol Med; 2001; 20(1):73-86. PubMed ID: 12673845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for sickle cell disease: where do we go from here?
    Walters MC
    J Pediatr Hematol Oncol; 1999; 21(6):467-74. PubMed ID: 10598656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for sickle cell disease: where we are now?
    Kanter J; Falcon C
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):174-180. PubMed ID: 34889358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
    Locatelli F; Pagliara D
    Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in sickle cell disease treatments: Towards targeted therapies].
    Arlet JB
    Rev Med Interne; 2020 Feb; 41(2):73-77. PubMed ID: 31771774
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction to a review series on gene therapy and gene editing for sickle cell disease and hemophilia.
    Bollard CM
    Blood; 2021 Sep; 138(11):913. PubMed ID: 34232977
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.
    Hossain MA; Bungert J
    Mol Ther; 2017 Mar; 25(3):561-562. PubMed ID: 28190778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.